Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Jul-24 5:30 PM View:  | BioSante Pharmaceuticals, I... (ANIP) | 18-Jul-24 | Private Sale (Planned) | 2,743 | $62.00 | $170,066.00 | (< 1%) 709.01K to 706.27K | |
| 17-Jul-24 7:07 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-Jul-24 | Sale (Planned) | 14,257 | $63.16 | $900,472.00 | (2%) 723.27K to 709.01K | |
| 17-Jul-24 7:07 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Jul-24 | Sale (Planned) | 22,000 | $64.27 | $1,413,940.00 | (3%) 745.27K to 723.27K | |
| 17-Jul-24 7:07 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Jul-24 | Private Sale (Planned) | 11,000 | $63.38 | $697,180.00 | (1%) 756.27K to 745.27K | |
| 24-Jun-24 4:12 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 21-Jun-24 | Private Sale (Planned) | 20,000 | $58.90 | $1,178,000.00 | (3%) 776.27K to 756.27K | |
| 20-Jun-24 7:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 20-Jun-24 | Sale (Planned) | 11,447 | $59.86 | $685,217.00 | (1%) 787.72K to 776.27K | |
| 20-Jun-24 7:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Jun-24 | Sale (Planned) | 10,607 | $60.76 | $644,481.00 | (1%) 798.33K to 787.72K | |
| 20-Jun-24 7:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-Jun-24 | Private Sale (Planned) | 7,946 | $61.41 | $487,964.00 | (< 1%) 806.27K to 798.33K | |
| 21-May-24 5:21 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 20-May-24 | Private Sale (Planned) | 12,855 | $61.81 | $794,568.00 | (2%) 819.13K to 806.27K | |
| 17-May-24 6:05 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-May-24 | Sale (Planned) | 5,836 | $62.09 | $362,357.00 | (< 1%) 824.96K to 819.13K | |
| 17-May-24 6:05 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-May-24 | Sale (Planned) | 16,459 | $63.84 | $1,050,740.00 | (2%) 841.42K to 824.96K | |
| 17-May-24 6:05 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-May-24 | Private Sale (Planned) | 14,850 | $65.86 | $978,021.00 | (2%) 856.27K to 841.42K | |
| 22-Apr-24 6:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 19-Apr-24 | Sale (Planned) | 16,809 | $65.17 | $1,095,440.00 | (2%) 873.08K to 856.27K | |
| 22-Apr-24 6:26 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Apr-24 | Private Sale (Planned) | 10,423 | $64.98 | $677,287.00 | (1%) 883.5K to 873.08K | |
| 17-Apr-24 4:33 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-Apr-24 | Sale (Planned) | 9,520 | $65.40 | $622,608.00 | (1%) 893.02K to 883.5K | |
| 17-Apr-24 4:33 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Apr-24 | Sale (Planned) | 5,834 | $66.20 | $386,211.00 | (< 1%) 898.86K to 893.02K | |
| 17-Apr-24 4:33 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Apr-24 | Private Sale (Planned) | 7,414 | $66.33 | $491,771.00 | (< 1%) 906.27K to 898.86K | |
| 11-Mar-24 6:43 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 08-Mar-24 | Private Sale (Planned) | 10,000 | $67.17 | $671,700.00 | (1%) 916.27K to 906.27K | |
| 07-Mar-24 9:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 07-Mar-24 | Sale (Planned) | 15,085 | $66.35 | $1,000,890.00 | (2%) 931.36K to 916.27K | |
| 07-Mar-24 9:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 06-Mar-24 | Sale (Planned) | 14,822 | $65.47 | $970,396.00 | (2%) 946.18K to 931.36K | |
| 07-Mar-24 9:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 05-Mar-24 | Private Sale (Planned) | 10,093 | $65.35 | $659,578.00 | (1%) 956.27K to 946.18K | |
| 01-Mar-24 5:18 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Feb-24 | Payment of Exercise | 1,122 | $67.67 | $75,925.70 | (< 1%) 957.39K to 956.27K | |
| 16-Feb-24 4:53 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Feb-24 | Grant | 22,367 | -- | -- | 2% 935.03K to 957.39K | |
| 23-Jan-24 5:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 23-Jan-24 | Sale (Planned) | 15,000 | $56.44 | $846,600.00 | (2%) 950.03K to 935.03K | |
| 23-Jan-24 5:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 22-Jan-24 | Sale (Planned) | 5,692 | $55.95 | $318,467.00 | (< 1%) 955.72K to 950.03K | |
| 23-Jan-24 5:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 19-Jan-24 | Private Sale (Planned) | 4,524 | $55.57 | $251,399.00 | (< 1%) 960.24K to 955.72K | |
| 18-Jan-24 6:20 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Jan-24 | Sale (Planned) | 9,784 | $55.30 | $541,055.00 | (1%) 970.03K to 960.24K | |
| 18-Jan-24 6:20 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-Jan-24 | Sale (Planned) | 10,000 | $55.11 | $551,100.00 | (1%) 980.03K to 970.03K | |
| 18-Jan-24 6:20 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Jan-24 | Private Sale (Planned) | 5,000 | $55.63 | $278,150.00 | (< 1%) 985.03K to 980.03K | |
| 19-Dec-23 5:44 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 19-Dec-23 | Sale (Planned) | 25,000 | $52.65 | $1,316,250.00 | (2%) 1.01M to 985.03K | |
| 19-Dec-23 5:44 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Dec-23 | Sale (Planned) | 13,026 | $52.44 | $683,083.00 | (1%) 1.02M to 1.01M | |
| 19-Dec-23 5:44 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Dec-23 | Private Sale (Planned) | 11,974 | $52.44 | $627,917.00 | (1%) 1.04M to 1.02M | |
| 16-Nov-23 6:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Nov-23 | Sale (Planned) | 6,448 | $51.66 | $333,104.00 | (< 1%) 1.06M to 1.05M | |
| 16-Nov-23 6:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Nov-23 | Sale (Planned) | 7,647 | $53.64 | $410,185.00 | (< 1%) 1.06M to 1.06M | |
| 16-Nov-23 6:11 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Nov-23 | Private Sale (Planned) | 22,095 | $53.17 | $1,174,790.00 | (2%) 1.09M to 1.06M | |
| 19-Oct-23 4:28 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 19-Oct-23 | Sale (Planned) | 10,000 | $57.06 | $570,600.00 | (< 1%) 1.1M to 1.09M | |
| 19-Oct-23 4:28 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Oct-23 | Sale (Planned) | 6,242 | $57.78 | $360,663.00 | (< 1%) 1.1M to 1.1M | |
| 19-Oct-23 4:28 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 17-Oct-23 | Private Sale (Planned) | 8,758 | $58.53 | $512,606.00 | (< 1%) 1.11M to 1.1M | |
| 17-Oct-23 4:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 16-Oct-23 | Sale (Planned) | 13,063 | $58.31 | $761,704.00 | (1%) 1.12M to 1.11M | |
| 17-Oct-23 4:32 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 13-Oct-23 | Private Sale (Planned) | 11,937 | $57.58 | $687,332.00 | (1%) 1.14M to 1.12M | |
| 19-Sep-23 5:14 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 19-Sep-23 | Sale (Planned) | 25,333 | $61.23 | $1,551,140.00 | (2%) 1.16M to 1.14M | |
| 19-Sep-23 5:14 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 18-Sep-23 | Sale (Planned) | 8,425 | $61.64 | $519,317.00 | (< 1%) 1.17M to 1.16M | |
| 19-Sep-23 5:14 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Sep-23 | Private Sale (Planned) | 16,242 | $62.81 | $1,020,160.00 | (1%) 1.19M to 1.17M | |
| 30-Aug-23 4:29 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 29-Aug-23 | Sale | 25,000 | $63.37 | $1,584,250.00 | (2%) 1.21M to 1.19M | |
| 30-Aug-23 4:29 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 28-Aug-23 | Private Sale | 25,000 | $63.06 | $1,576,500.00 | (2%) 1.24M to 1.21M | |
| 16-Aug-23 7:07 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 15-Aug-23 | Sale (Planned) | 22,110 | $61.60 | $1,361,980.00 | (2%) 1.26M to 1.24M | |
| 16-Aug-23 7:07 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 14-Aug-23 | Private Sale (Planned) | 27,890 | $61.15 | $1,705,470.00 | (2%) 1.29M to 1.26M | |
| 21-Jul-23 7:15 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 21-Jul-23 | Sale (Planned) | 11,500 | $52.56 | $604,440.00 | (< 1%) 1.3M to 1.29M | |
| 21-Jul-23 7:15 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 20-Jul-23 | Sale (Planned) | 6,000 | $51.52 | $309,120.00 | (< 1%) 1.3M to 1.3M | |
| 21-Jul-23 7:15 PM View: | BioSante Pharmaceuticals, I... (ANIP) | 19-Jul-23 | Private Sale (Planned) | 5,969 | $51.48 | $307,284.00 | (< 1%) 1.31M to 1.3M |